title: Different contents of glycosaminoglycans in a human neoplastic salivary duct cell line and its subclone with a myoepithelial phenotype.
abstract: The glycosaminoglycans (GAG) biosynthesized by a neoplastic human salivary duct cell line, HSGc, and by its nontumorigenic subclone, HSGc-E1, having a myoepithelial-like phenotype, were examined by incorporation of [3H]-acetate into GAG. The rate of GAG radiolabeling in HSGc-E1 was significantly greater than that in HSGc. The radiolabeled GAG recovered from HSGc-E1 showed a distribution of 22-32% in the cells and 68-78% secreted into the medium, while the amounts of GAG in the cells and medium of HSGc were equal. Two-dimensional electrophoresis of GAG extracted from the cells demonstrated that HSGc-E1 contained a much greater amount of heparan sulfate (HS, 53.5% of total), while HSGc synthesized hyaluronic acid (HA, 17.5%), HS 38.8%, chondroitin sulfate (Ch-S, 27.6%) and dermatan sulfate (DS, 16.1%). Moreover, treatment of HSGc with sodium butyrate or dibutyryl cyclic AMP (each is a potent inducer of differentiation to myoepithelial-like cells) strongly enhanced GAG synthesis, while dexamethasone (an inducer of differentiation to a more functional duct epithelium) did not stimulate GAG synthesis. These findings suggest that biosynthetic changes in the GAG content of neoplastic salivary cells are associated with their myoepithelial differentiation.
authors.affiliation: First Department of Oral and Maxillofacial Surgery, Osaka University Faculty of Dentistry, Japan.
authors.forename: K
authors.initials: K
authors.lastname: Shirasuna
authors.forename: H
authors.initials: H
authors.lastname: Furusawa
authors.forename: S
authors.initials: S
authors.lastname: Morioka
authors.forename: K
authors.initials: K
authors.lastname: Watatani
authors.forename: T
authors.initials: T
authors.lastname: Matsuya
mesh_terms: D002999:Clone Cells / Q000032:analysis; D004273:DNA, Neoplasm / Q000096:biosynthesis; D015180:Electrophoresis, Gel, Two-Dimensional; D006025:Glycosaminoglycans / Q000032:analysis* / Q000096:biosynthesis; D006801:Humans; D009208:Myoepithelioma / Q000032:analysis* / Q000473:pathology; D010641:Phenotype; D012468:Salivary Gland Neoplasms / Q000032:analysis* / Q000473:pathology; D014407:Tumor Cells, Cultured / Q000032:analysis / Q000473:pathology
chemical_list: D004273:DNA, Neoplasm; D006025:Glycosaminoglycans